
TY  - JOUR
TI  - Saturday, 15 June 2002
JO  - Contact Dermatitis
VL  - 46
IS  - s4
SN  - 0105-1873
UR  - https://doi.org/10.1034/j.1600-0536.46.s4.33.x
DO  - doi:10.1034/j.1600-0536.46.s4.33.x
SP  - 22
EP  - 32
PY  - 2002
ER  - 

TY  - JOUR
TI  - Abstracts: 48th Annual Conference of the American College of Veterinary Ophthalmologists, Baltimore, MD October 11-14, 2017
JO  - Veterinary Ophthalmology
JA  - Vet Ophthalmol
VL  - 20
IS  - 6
SN  - 1463-5216
UR  - https://doi.org/10.1111/vop.12519
DO  - doi:10.1111/vop.12519
SP  - E1
EP  - E19
PY  - 2017
ER  - 

TY  - JOUR
TI  - Poster Session 1
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 16
IS  - s2
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.93_4
DO  - doi:10.1002/ejhf.93_4
SP  - 19
EP  - 98
PY  - 2014
ER  - 

TY  - JOUR
TI  - Symposium session summaries
JO  - Pediatric Pulmonology
JA  - Pediatr. Pulmonol.
VL  - 22
IS  - S13
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.1950220705
DO  - doi:10.1002/ppul.1950220705
SP  - 78
EP  - 208
PY  - 1996
ER  - 

TY  - JOUR
TI  - TUESDAY SESSION
JO  - Journal of Neurochemistry
VL  - 94
IS  - s2
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.1474-1644.2005.03323.x
DO  - doi:10.1111/j.1474-1644.2005.03323.x
SP  - 64
EP  - 128
PY  - 2005
ER  - 

TY  - JOUR
TI  - Bristol Cup Posters
JO  - British Journal of Dermatology
JA  - Br J Dermatol
VL  - 179
IS  - S1
SN  - 0007-0963
UR  - https://doi.org/10.1111/bjd.16406
DO  - doi:10.1111/bjd.16406
SP  - 24
EP  - 73
PY  - 2018
ER  - 

TY  - JOUR
TI  - Joint meeting of the Pathological Society of Great Britain and Ireland and the Dutch Pathological Society (NVvP). 186th meeting of the Pathological Society of Great Britain & Ireland 6–9 July 2004
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 204
IS  - 1
SN  - 0022-3417
UR  - https://doi.org/10.1002/path.1712040102
DO  - doi:10.1002/path.1712040102
SP  - A1
EP  - A54
PY  - 2004
ER  - 

TY  - JOUR
TI  - ARTICLES RECEIVED IN 1987
JO  - Developmental Medicine & Child Neurology
VL  - 30
IS  - s56
SN  - 0012-1622
UR  - https://doi.org/10.1111/j.1469-8749.1988.tb08293.x
DO  - doi:10.1111/j.1469-8749.1988.tb08293.x
SP  - 9
EP  - 98
PY  - 1988
ER  - 

TY  - JOUR
TI  - The endothelial cell
JO  - Journal of Cellular Biochemistry
JA  - J. Cell. Biochem.
VL  - 44
IS  - S14E
SN  - 0730-2312
UR  - https://doi.org/10.1002/jcb.240440805
DO  - doi:10.1002/jcb.240440805
SP  - 191
EP  - 226
PY  - 1990
ER  - 

AU  - Müller, Lutz
AU  - Husar, Elisabeth
C7  - pp. 42-81
TI  - Preclinical Safety Testing
SN  - 9780470659878
UR  - https://doi.org/10.1002/9781118532331.ch3
DO  - doi:10.1002/9781118532331.ch3
SP  - 42-81
KW  - toxicity testing of pharmaceuticals
KW  - biologics
KW  - safety pharmacology
KW  - genetic toxicology
KW  - reproductive toxicity
KW  - carcinogenicity
KW  - impurities
KW  - juvenile toxicity
PY  - 1990
AB  - Summary Comprehensive preclinical safety testing in vitro and in animal models is mandatory when developing a potential new pharmaceutical compound. The primary objectives of such studies are to demonstrate that, under the conditions of human volunteer profiling and in therapy, the potential new drug is safe or its side effects can be monitored and managed. Hence, regulatory agencies need to be assured that the benefits of a new medicine outweigh the risks of therapy. Toxicologists have to assist clinicians in determining the likely range of safe exposures to the new pharmaceutical in appropriate animal and in vitro models and the possible consequences if these doses are exceeded. Early response surrogate biomarkers for toxicity can indicate when safety limits have been breached, but before significant damage has occurred. The chapter on preclinical safety describes the necessary experiments, their design and conduct versus the background of regulatory guideline expectations. The chapter also comprises expectations for animal safety testing of biologics, juvenile toxicity and describes new challenges for non-clinical safety studies such as the use of pluripotent stem cells.
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Reproduction in Domestic Animals
VL  - 45
IS  - s3
SN  - 9780470659878
UR  - https://doi.org/10.1111/j.1439-0531.2010.01654_3.x
DO  - doi:10.1111/j.1439-0531.2010.01654_3.x
SP  - 63
EP  - 113
PY  - 2010
ER  - 

TY  - JOUR
TI  - Current Awareness
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidem. Drug Safe.
VL  - 9
IS  - 3
SN  - 9780470659878
UR  - https://doi.org/10.1002/1099-1557(200005/06)9:3<257::AID-PDS489>3.0.CO;2-5
DO  - doi:10.1002/1099-1557(200005/06)9:3<257::AID-PDS489>3.0.CO;2-5
SP  - 257
EP  - 272
PY  - 2000
AB  - Abstract In order to keep subscribers up-to-date with the latest developments in their field, John Wiley  2 General; 3 Anti-infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non-steroidal Anti-inflammatory Agents; 7 CNS Agents; 8 Anti-neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator-Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti-inflammatory Agents - Steroidal; 19 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.
ER  - 

TY  - JOUR
TI  - Transcription: Factors, regulation and differentiation
JO  - Journal of Cellular Biochemistry
JA  - J. Cell. Biochem.
VL  - 53
IS  - S17A
SN  - 9780470659878
UR  - https://doi.org/10.1002/jcb.240530504
DO  - doi:10.1002/jcb.240530504
SP  - 53
EP  - 218
PY  - 1993
ER  - 

TY  - JOUR
TI  - Joint meeting of The Pathological Society of Great Britain and Ireland and the Dutch Pathological Society (NVvP) 186th Meeting of The Pathological Society of Great Britain and Ireland, Hosted by the Department of Pathology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands, 6–9 July 2004
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 204
IS  - S1
SN  - 9780470659878
UR  - https://doi.org/10.1002/path.1770
DO  - doi:10.1002/path.1770
SP  - 1A
EP  - 54A
PY  - 2004
ER  - 

TY  - JOUR
TI  - IV. Posters
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 51
IS  - S43
SN  - 9780470659878
UR  - https://doi.org/10.1002/ppul.23457
DO  - doi:10.1002/ppul.23457
SP  - S60
EP  - S89
PY  - 2016
ER  - 

AU  - Norris, Andrew W.
AU  - Wolfsdorf, Joseph I.
C7  - pp. 458-504
TI  - Diabetes Mellitus
SN  - 9781405180801
UR  - https://doi.org/10.1002/9781444316728.ch18
DO  - doi:10.1002/9781444316728.ch18
SP  - 458-504
KW  - diabetes mellitus
KW  - symptoms of hyperglycemia - polyuria, polydipsia, weight loss, polyphagia and blurred vision
KW  - diabetic ketoacidosis (DKA)
KW  - maturity onset diabetes of the young (MODY) - non-insulin-dependent type diabetes
KW  - thiamine-responsive megaloblastic anemia syndrome - mutations in thiamine transport gene
KW  - glucocorticoids - severe hepatic and peripheral insulin resistance
KW  - continuous subcutaneous insulin infusion (CSII)
KW  - oral hypoglycemic agents - moderate improvements of hyperglycemia
KW  - medical nutrition therapy (MNT)
KW  - self-monitoring of blood glucose (SMBG) - cornerstone of modern diabetes care
PY  - 2016
AB  - Summary This chapter contains sections titled: Definition and diagnosis of diabetes in children Type 1 diabetes mellitus Type 2 diabetes mellitus Presentation Differential diagnosis Management Acute complications of diabetes Side effects of treatment Chronic complications of type 1 diabetes Co-morbidities and complications of type 2 diabetes Transition from pediatric to adult care Conclusions References
ER  - 

TY  - JOUR
TI  - Abstract of the international association for the study of the liver. Biennial scientific meeting
JO  - Hepatology
JA  - Hepatology
VL  - 16
IS  - 2
SN  - 9781405180801
UR  - https://doi.org/10.1002/hep.1840160242
DO  - doi:10.1002/hep.1840160242
SP  - 511
EP  - 612
PY  - 1992
ER  - 

TY  - JOUR
TI  - Growth and differentiation factors in development
JO  - Journal of Cellular Biochemistry
JA  - J. Cell. Biochem.
VL  - 44
IS  - S14E
SN  - 9781405180801
UR  - https://doi.org/10.1002/jcb.240440803
DO  - doi:10.1002/jcb.240440803
SP  - 31
EP  - 130
PY  - 1990
ER  - 

AU  - Dutta, Anand S
C7  - pp. 1-86
TI  - Discovery of New Medicines
SN  - 9780727918406
UR  - https://doi.org/10.1002/9780470987391.ch1
DO  - doi:10.1002/9780470987391.ch1
SP  - 1-86
KW  - bone disorders
KW  - therapeutic agents
KW  - metalloproteinases
KW  - cyclooxygenase
KW  - gene therapy
PY  - 1990
AB  - Summary This chapter contains sections titled: Introduction Market Needs and Changing Disease Patterns Historical Aspects Impact of New Technology on Drug Discovery Examples of Drug Discovery Enzymes and Enzyme Inhibitors Protein-Protein Interaction Inhibitors Protein and Antibody Therapeutics Examples of Currently Available Drugs for Major Diseases Summary
ER  - 

TY  - JOUR
TI  - Abstracts of the 21st Annual Meeting of the European Society for Clinical Investigation, March 21 -24, Copenhagen-Elsinore, Denmark
JO  - European Journal of Clinical Investigation
VL  - 17
IS  - 2
SN  - 9780727918406
UR  - https://doi.org/10.1111/j.1365-2362.1987.tb02041.x
DO  - doi:10.1111/j.1365-2362.1987.tb02041.x
SP  - A3
EP  - A71
PY  - 1987
ER  - 
